Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...
Hlavní autoři: | Morgan, R, O'Callaghan, J, Knight, SR, Morris, P |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2012
|
Podobné jednotky
-
Systematic reviews of alemtuzumab in renal transplantation.
Autor: O'Callaghan, J, a další
Vydáno: (2013) -
Systematic reviews of alemtuzumab in renal transplantation
Autor: O'Callaghan, J, a další
Vydáno: (2013) -
Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
Autor: O'Callaghan, J, a další
Vydáno: (2013) -
Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
Autor: O'Callaghan, J, a další
Vydáno: (2012) -
Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
Autor: O'Callaghan, J, a další
Vydáno: (2012)